Individualised dosage by SC inj in the upper arms, thighs, buttocks, or abdomen. Vial/cartridge Can be administered by continuous SC infusion pump, or by IV.
Transferring to another type or brand of insulin; change in strength, brand (manufacturer), type, species, &/or method of manufacture. Conditions which may make early warning symptoms of hypoglycaemia less pronounced or different eg, long duration of diabetes, intensified insulin therapy, diabetic nerve disease or medications eg, β-blockers. Risk of hyperglycaemia & diabetic ketoacidosis w/ inadequate dosages or treatment discontinuation, especially in insulin-dependent diabetics. Increased insulin requirements during illness or emotional disturbances. Reduced insulin requirement in patients w/ renal or hepatic impairment. Increased insulin resistance in patients w/ chronic hepatic impairment. Dose adjustments may be necessary in case of increased physical activity or change in diet. Reports of cardiac failure in combination w/ pioglitazone. Perform continuous rotation of inj site to reduce risk of developing lipodystrophy & cutaneous amyloidosis. Patients who are blind or have poor vision must get help/assistance from another person who has good vision & is trained in using the insulin device. May impair ability to drive & use machines. Pregnancy & lactation.
Sign Out
 100 u_mL8b26d876-0823-4975-a990-a7b300eb9233.GIF)
 100 u_mL484a382a-1d6f-4423-a391-a07c008cfed9.GIF)
 100 u_mL7e50d036-897a-4b5d-9e65-9fab010a50e8.GIF)
